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ICAM-1 is the major accessory molecule. In addition, HPMCsAccessory role of human peritoneal mesothelial cells in antigen
may contribute to T-cell activation by secretion of IL-15.presentation and T-cell growth.
Background. To assess the role of human peritoneal meso-
thelial cells (HPMCs) in the generation of an immune response
during peritonitis, we tested their ability to activate T-cells by The peritoneal cell population consists mainly ofantigen presentation (AP) and by the secretion of interleukin-
mesothelial cells. It is now clear that in addition to its15 (IL-15). IL-15 is a potent leukocyte activator that stimulates
structural function, this cell layer plays an important rolethe proliferation of CD41, CD81, and B and natural killer
(NK) cells. in the peritoneal inflammatory response. The relatively
Methods. HPMCs and mononuclear cells were derived from large surface (,2 m2) of uninfected peritoneum is usually
six volunteer patients who underwent elective abdominal sur- surveyed by a limited number of leukocytes consistinggery. Flow cytometry was used to analyze human lymphocyte
mainly of macrophages [1]. To mount an effective im-antigen-DR (HLA-DR), intercellular adhesion molecule-1
mune response against invading pathogens, a large num-(ICAM-1), and B7 molecules on HPMCs. Affinity-purified
CD4 cells were used for AP assays. We used a specific enzyme- ber of leukocytes are recruited to the peritoneum from
linked immunosorbent assay to detect interferon-g (IFN-g), the blood by a process in which human peritoneal meso-
IL-2, and IL-15 protein and reverse transcription-polymerase thelial cells (HPMCs) play an important role. In response
chain reaction for mRNA analysis.
to bacterial and inflammatory mediators, HPMCs wereResults. HPMCs expressed HLA-DR molecules following
shown to secrete the proinflammatory cytokines interleu-IFN-g treatment. ICAM-1 molecules were expressed at high
levels, and B7-1 and B7-2 molecules could not be detected. The kin-1 (IL-1) and IL-6 and the chemokines IL-8 monocyte
accessory function of HPMCs was assayed by T-cell stimulation chemoattractant protein-1 (MCP-1), and RANTES, thus
using anti-CD3 antibodies (OKT3). HPMCs were essential for amplifying the inflammatory signals and inducing effec-
a significant OKT3-induced T-cell proliferation. Anti–ICAM-1 tive endothelial activation needed to cause the migrationantibodies blocked OKT3-induced proliferation. HPMCs served
of leukocytes to the peritoneal cavity [2–7]. We believeas effective antigen-presenting cells when Tetanus toxoid (TT)
that HPMCs have additional roles in subsequent immuneor Staphylococcus aureus-a-toxin were used as antigens. IFN-g,
IL-2, and IL-15 accumulated during AP reactions. We found processes in which T cells are mainly involved.
that IL-15 is produced by HPMCs, and IFN-g up-regulated The immune response is mainly controlled by T-helper
its mRNA levels and protein secretion in a dose-dependent (Th) cells recognizing by their T-cell receptor (TCR) the
manner. We also detected IL-15 in the peritoneal effluent of
foreign antigen, which is presented on major histocom-patients undergoing continuous peritoneal dialysis treatment.
patibility complex (MHC) class 2 molecules. Foreign anti-In patients suffering from peritonitis, IL-15 levels were elevated
(35.0 6 6.0 pg/mL, N 5 10) as compared with noninfected gen recognition stimulates T cells to release potent im-
patients (16.2 6 4.0 pg/mL, N 5 7). mune mediators, such as IL-2 and interferon-g (IFN-g),
Conclusions. HPMCs participate in the peritoneal immune which leads to an immune response against the invader
response against invading pathogens by AP. For this process,
[8]. Thus, antigen presentation (AP) is a key event in
the immune response. Recognition of a foreign antigen
by Th cells is completely dependent on its presentationKey words: T lymphocytes, interleukin-15, interferon-g, immune re-
sponse, leukocytes, peritonitis. by MHC class 2 molecules. In contrast to the common
expression of class I molecules on various cells and tissue,
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phages, monocytes, and B cells [9]. All other cells usually Cell preparation
do not express class 2 molecules. However, following Human peritoneal mesothelial cells. HPMCs were iso-
stimulation with various cytokines, class 2 molecules lated from pieces of omentum of approximately 6 cm2
were found on nonprofessional APC, including endothe- obtained during elective abdominal surgery, as pre-
lial cells, keratinocytes, and renal proximal tubular cells. viously reported [22]. The pieces of omentum were
These cells can also present antigens to Th cells [9–12]. washed in phosphate-buffered saline (PBS) and then cut
The contact of the TCR to class 2 molecules presenting into pieces of approximately 1 mm3. The disaggregation
a foreign antigen is indispensable; however, to obtain of the tissue was performed in a 50 mL centrifuge tube
an effective T-cell activation, T cells must also contact using 0.2% collagenase A (Boehringer Mannheim, Mann-
specific accessory molecules on the presenting cells. The heim, Germany) in M199 medium containing 10% fetal
calf serum (FCS), 2 mmol/L l-glutamine, 100 U/mL peni-major accessory molecules found on professional APC
cillin, 100 mg/mL streptomycin, and Biogro 2e (Biologi-are considered to be B7-1 and B7-2 molecules. In some
cal Industries, Bet Haemek, Israel), which was continu-cases, mainly in nonprofessional APC, the adhesion mol-
ously stirred for one hour at 378C. The mesothelial cellsecule intercellular adhesion molecule-1 (ICAM-1) was
were washed three times in PBS and then seeded in aalso demonstrated to be an effective accessory molecule
75 cm2 tissue culture flask (Bibby, Corning, NY, USA)[9, 12].
with M199 medium containing the previously mentionedValle et al have demonstrated that HPMCs are able
supplements. After reaching confluence, cells were tryp-to present a soluble antigen [tetanus toxoid (TT)] and
sinized [trypsin-ethylenediaminetetraacetic acid (EDTA),Candida albicans bodies in an experimental system com-
solution B; Biological Industries] and washed and dilutedposed of mononuclear cells depleted of adherent cells
in fresh medium. Experiments were performed on cells[13]. In this study, we used highly purified autologous
from the second to fourth passages. The cells in thisTh cells to investigate the AP function and the accessory
passages had a uniform cobblestone appearance, andfunction of HPMCs. In addition, we tested the ability of
micovilli were present. HPMCs were positive for cyto-HPMCs to produce and secrete IL-15, a growth factor
keratine and vimentin, as detected by indirect fluores-and activator of T cells. IL-15 has been recently described
cence (BM#6557 and BM#6079 antibodies; Sigma, Reho-as a cytokine with biological functions similar to those
vot, Israel), which are characteristic of mesothelial cellsof IL-2, but with no significant sequence homology. IL-15
[23]. The cultured cells did not contain cells expressingand IL-2 are members of the four a helix bundle cytokine
CD68 (Dako, Copenhagen, Denmark; patts-M-814), afamily. Both cytokines use a receptor composed of three
macrophage/monocyte marker, were free from CD141subunits: (a) the IL-2 receptor b-chain; (b) a g-chain
cells (tested by immunofluorescence; Becton-Dickinson,(gc) shared by IL-15, IL-2, IL-4, IL-7, and IL-9 receptors;
Mountain View, CA, USA), and were factor VIII nega-and (c) a unique a-chain. The a-chain of the IL-15 recep-
tive.tor (IL-15Ra) and IL-2Ra share a fragmentary sequence
CD41 T cells. Enrichment of CD41 depleted from
homology and structural similarities, and both proteins
CD141 cells from peripheral blood mononuclear cells
contain a conserved “sushi domain”-binding motif. IL-15
(PBMCs) was done by initially removing adherent cells
is a potent T-cell activator that induces the effector func- by two successive incubations followed by magnetic af-
tion of cytotoxic T cells and lymphokine-activated killer finity removal of CD141 cells and magnetic affinity en-
cells. IL-15, like IL-2, stimulates the proliferation of acti- richment of CD41 cells. Mononuclear cells were isolated
vated CD4, CD8, B, and natural killer (NK) cells [14, 15]. from 50 mL heparinized venous blood by standard cen-
Interleukin-15 mRNA has been demonstrated to be trifugation over a Hystopaque 1077 cushion (Sigma). The
present in placenta, skeletal muscle, kidney, lung, heart, PBMCs were washed three times with PBS and seeded
keratinocytes, macrophages, Langerhans cells, dendritic into a 150 cm2 culture tissue flask in RPMI 1640 medium
cells, astrocytes, microglia cells, endothelial cells, and containing 10% heat-inactivated pooled human AB se-
intestinal epithelial cells. In contrast to IL-2, IL-15 is not rum, 2 mmol/L l-glutamine, 100 U/mL penicillin-100
produced by T lymphocytes [16–21]. The aim of this mg/mL streptomycin, and 50 mmol/L b-mercaptoethanol
study was to examine the support given by mesothelial and incubated for 1.5 hours in a standard CO2 incubator
cells to T cells by AP and by the release of IL-15. (5% CO2 at 378C). Following the first incubation, the
nonadherent cells were transferred to a new flask for
a second incubation, and then nonadherent cells were
METHODS collected and resuspended in PBS containing 0.5% bo-
Human peritoneal mesothelial cells and mononuclear vine serum albumin (BSA). Residual nonadherent
cells were obtained from six volunteers: two women and CD141 cells (mainly monocytes) were removed using
the MiniMACS magnetic cell sorting system (Miltenyifour men with ages ranging from 32 to 55 years.
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Biotec, Sunnyvale, CA, USA) according to the manufac- CD41 T cells (105 cells/well) were added to wells with or
without preseeded HPMCs. Medium or OKT3 (1 mg/mL;turer’s protocol. Briefly, nonadherent mononuclear cells
were mixed with MACS colloidal supermagnetic mi- Orto-Biotec, Raritan, NJ, USA) or TT (5 mg/mL; Calbio-
chem, La Jolla, CA, USA) or Staphylococcus aureuscrobeads conjugated with monoclonal antihuman CD14
antibodies (Miltenyi Biotec) and incubated for 15 min- a-toxin (1 mg/mL; Calbiochem) were added, and the final
volume was adjusted with medium to 250 mL in eachutes at 48C. The cells were washed and loaded on the
magnetic column. The effluent, negative for CD14 cells, well. Optimal concentrations of OKT3 and antigens and
cell number were adjusted in preliminary experiments.was collected, and washed cells were counted and incu-
bated with MACS microbeads conjugated with antihu- Inhibition of ICAM-1 was done by adding anti-CD54 (1
mg/mL; Serotec) to the reaction well. An isotype anti-man CD4 antibodies (Miltenyi Biotec). The labeled cells
were loaded on the magnetic column, and then the col- body (mouse IgG1) at the same concentration was used
in control wells. Cells were incubated for six days, andumn was washed to remove the non-CD4 cells. The col-
umn was then separated from the magnet, and the CD41 six hours before harvest, a pulse of 3H-thymidine (1 m
Ci/well, specific activity of 5 Ci/mmol; Nuclear Researchcells were flushed out and resuspended in RPMI 1640
medium. By flow cytometry analysis, we found that more Center, Negev, Israel) was added. Cells were harvested
on a fiberglass filter using a cell harvester (Inotech, Dotti-than 99% of the cells were CD4 positive and negative
for the monocyte/macrophage marker CD14. kon, Switzerland). Proliferation was assessed as 3H-thy-
midine incorporation determined by densitometry afterMonocytes. The adherent fractions of the first PBMC
incubation, described in the previous section, contained exposure of the filter to a radioactive imager (Fujix-BAS
1000; Fuji, Tokyo, Japan).over 85% monocytes and were used as professional APC
for comparison with mesothelial cells. For measurement of the cytokine levels, several AP
experiments were performed in 24-well plates in parallel
Flow cytometry to the standard 96-well assays. HPMCs were seeded (4 3
104 cells/well) and incubated overnight. Then CD41 TFor flow cytometry analysis, HPMCs (0.5 3 106 cells)
were harvested by an EDTA solution (1:2000; Biological cells (4 3 105 cells/well) were added and incubated in a
final volume of 1 mL for three or six days in the presenceIndustries) and then washed and incubated in 100 mL
PBS containing 0.5% BSA for one hour on ice with of TT (5 mg/mL; Calbiochem) or medium alone. Follow-
ing incubation, supernatants were collected and sub-anti–ICAM-1 (anti-CD54; Serotec, Oxford, UK) or anti–
HLA-DR (Dako) or anti–B7-1 (anti-CD80; Pharmingen, sequently assayed for IL-2 and IFN-g using specific com-
mercial enzyme-linked immunosorbent assay (ELISA)San Diego, CA, USA) or anti–B7-2 (anti-CD86; Phar-
mingen). Then the cells were washed and incubated with kits (R&D Systems, Minneapolis, MN, USA). IL-15 was
measured as described later in this article.fluorescein (FITC)-conjugated F(ab9) antimouse IgG-
IgM (Jackson, West Grove, PA, USA). The antibodies
Human peritoneal mesothelial cell activation protocolswere diluted to recommended concentrations according
to the manufacturers’ instructions. HLA-DR on HPMCs Human peritoneal mesothelial cells (2 3 104 cells/well)
were seeded in 12-well plates (Bibby) and incubated forwas induced by a 16-hour incubation with 500 U/mL or
2000 U/mL of recombinant human IFN-g. Background 48 hours to reach confluence. Cells were washed twice
with medium and incubated for different lengths of timefluorescence was adjusted with cells labeled with match-
ing isotype control antibodies as the first antibody. How- with 0.5 mL of M199 medium containing various concen-
trations of Escherichia coli 055:B5 lipopolysaccharideever, HPMCs had no affinity to control antibodies, and
fluorescence levels were always similar to that seen in (LPS; 10 mg/mL; Sigma), rhIL-2 (100 U/mL), or IFN-g
(0.5 to 500 U/mL). At different time points, the superna-nonstained cells. Analyses were done on a FACStar flow
cytometer (Becton Dickinson). tant was collected and stored at 2208C for later assay
of IL-15. Total IL-15 (cell associated and secreted) was
Accessory and antigen-presentation assay obtained by lysis of the cells with NP40 added to superna-
tants in a final concentration 0.1% and collection of cellThe HPMC’s accessory function and AP were assayed
in 96-well plates (Bibby). lysates after 30 minutes of incubation on ice. The pres-
ence of 0.1% NP40 had no effect on the IL-15 ELISA.Human peritoneal mesothelial cells were seeded in 96-
well flat-bottomed plates (104 cells/well) and incubated Lactate dehydrogenase (LDH) was undetectable in the
supernatants collected during the experiments, indicat-overnight with complete RPMI 1640 medium. During
the last 30 minutes of incubation, mytomicin-C was ing that the experimental conditions were not toxic to
the cells. Cells from two wells were counted in each plateadded (25 mg/mL; Sigma) to block 3H-thymidine uptake
by HPMCs. Mytomicin-C treatment had no visible effect for definition of cell number per well. The similarity of
conditions in different experiments was demonstratedon the HPMC monolayer during the AP experiments.
The cells were then washed three times, and autologous by measuring the total LDH activity of cell lysates in
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each well. All tissue culture reagents contained less than run. PCR was run for 20 to 30 cycles with b-actin primers
under the following conditions: 90 seconds at 948C, then0.025 ng/mL of endotoxin.
5 to 15 cycles of 45 seconds each at 948C, 1.5 minutes at
Interleukin-15 mRNA analysis 608C, and 1 minute at 728C. The last 15 cycles were run
under the same conditions but, at 728C, was prolongedInterleukin-15 mRNA was determined by reverse
transcription-polymerase chain reaction (RT-PCR) of by five seconds in each cycle. PCR with IL-15 primers
was run with the same protocol except that the annealingtotal RNA extracted from HPMCs. RT-PCR and video
densitometry were performed as previously described temperature was 558C instead of 608C. Every experiment
was amplified with at least two different cycle numbers[2]. HPMCs were seeded in 12-well plates as described
previously in this article. Each experimental set was per- to ensure amplification in the exponential phase of PCR.
We found that 25 to 30 cycles for IL-15 and 20 toformed in triplicate. At the end of each experiment, cells
were washed once with cold PBS and lyzed with 1 mL 25 cycles for b-actin were in the exponential phase of
amplification, thus permitting comparison of mRNA lev-of Tri Reagente (Molecular Research Center, Inc., Cin-
cinnati, OH, USA). The resulting suspensions were els in different samples. Under these conditions, we also
found a linear dose-response of the PCR product totransferred to Eppendorf tubes and stored at 2708C for
later RNA extraction. Total RNA was extracted from increasing doses of cDNA.
Eight microliters of each sample containing amplifiedcells according to the Tri Reagente protocol. Suspen-
sions were thawed, and 200 mL of chloroform were added cDNA of IL-15, together with 8 mL of the corresponding
sample containing amplified cDNA of b-actin, wereto each tube. Tubes were then vortexed for 15 seconds
and after five minutes of incubation at room temperature loaded on an agarose gel (2%) containing ethidium bro-
mide (0.5 g/mL). A DNA size marker was run on thewere centrifuged for 30 minutes at 48C in a Microfuge E
(Beckman Instruments Inc., Palo Alto, CA, USA). From same gel (“123 bp ladder”; GIBCO BRL). PCR products
were quantitated by video densitometry of agarose geleach tube, 450 mL of the upper phase were transferred
to a new tube, and RNA was precipitated by adding 450 with the UVP GDS 5000 system (UVP Inc., San Gabriel,
CA, USA). To correct for differences in loading, densito-mL of isopropanol. Following incubation for 45 minutes
on ice and 15 minutes of centrifugation at 48C, the pellet metric values of IL-15 cDNA were corrected with corre-
sponding values of b-actin cDNA. To allow comparisonwas briefly washed by 75% ethanol and then dried and
resuspended in 0.3 mol/L sodium acetate and 2.5 volumes of different gels, the densitometric IL-15/b-actin ratios
were normalized for the IL-15/b-actin ratio of unstimu-of cold ethanol. RNA suspension was kept at 2708C.
For cDNA generation, RNA was precipitated and lated HPMCs run in each gel.
dried. Each sample was then dissolved in 12 mL of water
Assay of interleukin-15 proteinand heated for 10 minutes to 658C. To each RNA sample,
a reverse transcriptase reaction mixture was added con- Interleukin-15 in supernatants and cell lysates was
measured in duplicate using ELISA to human IL-15 withtaining 1 mL of Moloney murine leukemia virus-reverse
transcriptase (MMLV-RT, 200 U/mL; GIBCO BRL, commercially available antibodies (R&D Systems). Fol-
lowing the protocol of the manufacturer, ELISA platesGaithersburg, MD, USA), 4 mL of 53 reverse tran-
scriptase buffer (GIBCO BRL), 0.5 mL dithiothreitol (type 2592; Costar, Cambridge, MA, USA) were coated
overnight at room temperature with monoclonal antihu-(0.1 mol/L; GIBCO BRL), 0.5 mL RNase inhibitor (40
U/mL; Boehringer Mannheim), 1 mL oligo-d(T) 12-18 man IL-15 antibody (type MAB647) diluted in PBS to a
final concentration of 2 mg/mL. Plates were then washedmer (40 pmol/mL; Boehringer Mannheim), and 1 mL
dNTPs (2.5 nmol/mL of each nucleotide; Boehringer three times with washing buffer (0.05% Tween 20 in
PBS) and incubated for one hour with blocking bufferMannheim). The tube was incubated for one hour at
378C. Then the volume of each sample was adjusted to (1% BSA, 5% sucrose, and 0.05% NaN3 in PBS). Plates
were washed three times, and samples or rhIL-15 stan-60 mL, and the enzyme was inactivated by incubation
for 10 minutes at 658C. dards (3 to 300 pg/mL; R&D Systems) were added to
the wells. Wells were incubated for two hours at roomInterleukin-15 and b-actin cDNA were then amplified
by PCR using specific primers (Table 1). Five microliters temperature. Then the plates were incubated for two
hours with biotinylated monoclonal antihuman IL-15 an-of reverse transcription product were added to 45 mL of
PCR reaction mixture containing 32.75 mL H2O, 2.5 mL tibody (type BAM247, 100 mL/well) diluted to a final
concentration of 100 ng/mL in Tris-buffered saline (2059 primer (20 mmol/L), 2.5 mL 39 primer (20 mmol/L),
2 mL dNTPs (2.5 nmol/mL each nucleotide; Boehringer mmol/L Trizma base, 150 mmol/L NaCl, pH 7.3, with
0.1% BSA and 0.05% Tween 20). Plates were then incu-Mannheim), 5 mL of 103 reaction buffer, and 0.25 mL
Red Hot DNA polymerase (5 U/mL; Advanced Biotech- bated for 20 minutes with streptavidin horseradish perox-
idase (type 43-4323; 1:20,000, 100 mL/well; Zymed, Sannologies, Surrey, UK). A negative control consisting of
the reaction mixture without cDNA was included in each Francisco, CA, USA). Finally, 100 mL tetramethylbenzi-
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Table 1. Primer sequences used in RT-PCR
Gene Oligonucleotide sequence Product size
IL-15 59 primer 59-CCATAGCCAGCTCTTCTTC-39 290 bp
39 primer 59-GGTGAACATCACTTTCCG-39
b-actin 59 primer 59-GGGTCAGAAGGATTCCTATG-39 237 bp
39 primer 59-GGTCTCAAACATGATCTGGG-39
dine solution (“TMB Single Solution”; Zymed) were with the anti-CD3 antibody (OKT3) in the presence or
added, and plates were incubated for 20 minutes. ELISA absence of HPMCs. OKT3 stimulation bypasses antigen
reaction was stopped with 100 mL of H2SO4 (1 N). Optical recognition by TCR and directly activates the signaling
density was read with an ELISA reader at 450 nm and CD3 molecules. As shown in Figure 2, the presence of
at 550 nm for reference. The sensitivity of the assay was HPMCs was necessary for OKT3-induced proliferation.
2.0 pg/mL. No significant cross-reactivity or interference The 3H-thymidine uptake of OKT3-stimulated CD41
was observed with other cytokines. NP40 at 0.1% had cells was 5- to 16-fold higher than unstimulated cells
no detectable effect on the assay. and was found to be statistically significant in all the
experiments. Without HPMCs, the 3H-thymidine incor-
Peritoneal effluents poration levels of OKT3-stimulated T cells were similar
We measured the IL-15 levels in the morning effluents to unstimulated cells. It should be noted that higher
of patients undergoing continuous ambulatory perito- concentrations of OKT3 antibody induce low T-cell pro-
neal dialysis (CAPD) treatment. The effluents were ob- liferation without HPMCs. Therefore, in preliminary ex-
tained from 7 patients free of peritonitis for more than periments, we adjusted the concentration of the OKT3
three months and from 10 patients with peritonitis. The antibodies to obtain a low background. As depicted in
effluents were centrifuged (900 g for 10 min), and the Figure 2, OKT3 activation of CD41 cells in the presence
supernatants were kept at 2208C until assayed for IL-15 of HPMCs was fully blocked by an anti-CD54 (ICAM 1)
levels by ELISA. Patient profiles (age, sex, and time in antibody. A control antibody with the same isotype at
CAPD treatment) in these two groups were similar. the same concentration had no effect on OKT3-induced
T-cell proliferation.Statistics
Results are expressed as mean 6 se. Analyses of vari- Superantigen (a-toxin) presentation by human
ance or Student’s t-test were used in statistical analysis. peritoneal mesothelial cells
P values below 0.05 were considered significant. Staphylococcus aureus is a common pathogen of pa-
tients undergoing CAPD treatment, causing severe peri-
tonitis. The a-toxin of S. aureus belongs to the familyRESULTS
of superantigens. Superantigens externally bind class 2Flow cytometry analysis of HLA-DR, B7-1, B7-2, and
molecules without the regular process of internalizationICAM-1 molecules on HPMC
and cleavage needed for presentation of regular peptidesHuman peritoneal mesothelial cells were analyzed for
by APC. As shown in Figure 3, similar to OKT3, thethe expression of class 2 and accessory molecules by flow
presence of HPMCs was essential for an effective re-cytometry. As shown in Figure 1, the expression of class
sponse of CD41-T-cells to a-toxin. No proliferation of2–HLA-DR molecules was IFN-g dependent. No expres-
T cells above background was observed when a-toxinsion of class-2 HLA-DR molecules on HPMCs could be
was added to T cells alone. The magnitude of responsedetected in unstimulated cells, and IFN-g strongly up-
to a-toxin was always lower than the response to OKT3regulated the expression of HLA-DR in a dose-
(7 to 12 times lower depending on the subject). In onedependent manner. The B7.1 and B7.2 accessory mole-
case out of five, the proliferation of CD41 cells in thecules could not be detected on HPMCs. In contrast,
presence of HPMCs and a-toxin was not significantlyICAM-1 was constitutively expressed on mesothelial
higher than CD41 and mesothelial cells without a-toxin.cells. IFN-g had a minor up-regulatory effect on ICAM-1
expression but no effect on the expression of B7-1 and
Presentation of a regular antigenB7-2 molecules.
(Tetanus toxoid) by HPMC
Testing the accessory function of HPMC using Tetanus toxoid has to be internalized and processed
OKT3 antibodies in order to be presented by an APC. The CD41 lympho-
cytes of three out of six healthy subjects we tested hadTo test the accessory function of mesothelial cells,
highly purified CD41 T lymphocytes were stimulated a significant response TT. As depicted in Figure 3, like
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Fig. 1. Flow cytometry analysis of HLA-DR, B7-1, B7-2, and intercellular adhesion molecule-1 (ICAM-1) molecules on human peritoneal
mesothelial cells (HPMCs). HPMCs were stimulated with various concentrations of IFN-g for 16 hours and then labeled by a primary antibody
to (A) HLA-DR, (B) B7-1 (CD80), (C) B7-2 (CD86), and (D) ICAM-1 (CD54) molecules. Following staining with an FITC-labeled secondary-
antibody, the cells were analyzed in a FACStar flow cytometer. The shaded portion indicates the background fluorescence of cells labeled with
an isotype control antibody. The plain line indicates unstimulated cells, and the dashed line indicates IFN-g–stimulated cells. (A and B) IFN-g
concentrations are indicated by arrows. (C and D) The dashed line indicate stimulation with 2000 U/mL of IFN-g.
OKT3 and a-toxin, the T-cell response to TT was fully IL-2 and IFN-g in the supernatants of the nonresponsive
dependent on the presence of HPMCs. To test whether subject, and the levels of IL-15 were lower (undetectable
the unresponsiveness of CD41 lymphocytes of half of at day 3 and 12 pg/mL at day 6).
our tested subjects is not dependent on the type of APC, Interestingly, the addition of IFN-g (250 to 1000 U/mL)
we assayed two responsive and two nonresponsive lym- to HPMC before or during AP assay, with a-toxin or
phocyte preparations with autologous monocytes as TT, had no significant effect on T-cell proliferation (data
APC. Replacing HPMCs with monocytes, which are clas- not shown).
sic APCs, had no effect on the T-cell response to TT
(the nonresponsive T-cells remain unresponsive in the Interleukin-15 production by HPMC
presence of monocytes; Fig. 4).
It is generally recognized that AP induces the secretionThese three subjects were also followed-up in a paral-
of IL-2 and IFN-g from Th cells [8]. We therefore testedlel experimental system for cytokine production during
the ability of HPMCs to produce and secrete IL-15, aAP by HPMCs (data not shown). In cell supernatants
potent T-cell activator, when stimulated by those cytokines.of the two responsive subjects, we found detectable levels
Figure 5 shows total (cell associated and secreted) IL-15of IL-2 (55 6 8 pg/mL at day 3 and 67 6 4 pg/mL at
levels in control and stimulated HPMCs. Low basalday 6), IL-15 (14 6 3 pg/mL at day 3 and 20 6 2 pg/mL
IL-15 levels were found in control cells and LPS andat day 6) and IFN-g (48 6 5 pg/mL at day 3 and 59 6
6 pg/mL at day 6). In contrast, there was no detectable IL-2–stimulated cells. In contrast to LPS and IL-2, IFN-g
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Fig. 4. Tetanus toxoid presentation by monocytes. HPMCs were re-
Fig. 2. Role of ICAM-1 in the accessory function of HPMCs. The placed with monocytes as professional APC to test the unrespon-
accessory function of HPMCs for lymphocyte activation was assayed siveness to TT of three out of six T-cell preparations. This depicts the
in autologous mixed CD41-lymphocytes-HPMC assay in the presence representative 3H-thymidine uptake of lymphocytes from two subjects,
of OKT3 antibodies. OKT3 antibodies bypass recognition by T-cell one TT-responsive (j) and the other nonresponsive (h), assayed in
receptor by direct stimulation of the T-cell receptor signaling mole- mixed lymphocytes monocytes reaction. The assay was performed in
cules-CD3. ICAM-1 function was inhibited with a specific antibody 96-well plates. Monocytes (104 cells/well) were pretreated with mytomi-
(anti-CD54). The assay was performed in 96-well plates. HPMCs (104 cin-C. Similar results were obtained with cells of two additional sub-
cells/well) were pretreated with mytomicin-C. At day 6, lymphocyte jects. *P , 0.05 over control reaction without antigen.
proliferation was determined by 3H-thymidine incorporation. The fig-
ure is a representative experiment performed in triplicate out of three
similar experiments performed on cells from different subjects. *P ,
0.05 over control reaction without OKT3; ^P , 0.05 lower than control
reaction without anti-CD54.
Fig. 5. Interleukin-15 (IL-15) levels in stimulated HPMCs. HPMCs
in 12-well plates were stimulated for 24 hours with lipopolysaccharide
Fig. 3. Antigen presentation by HPMCs. Antigen presentation (AP) (LPS; 10 mg/mL), recombinant human IL-2 (rhIL-2; 100 U/mL), or
by HPMCs were assayed in an autologous mixed CD41-lymphocytes interferon gamma (IFN-g; 500 U/mL). Total IL-15 levels (cell associ-
HPMC reaction. We used Staphylococcus aureus a-toxin (h) or Teta- ated and secreted) were determined by specific ELISA in cell lysates.
nus toxoid ( ; TT) as antigens. At day 6, lymphocyte proliferation *P , 0.05 over unstimulated control. The results are mean 6 se
was determined by 3H-thymidine incorporation. The figure depicts a of experiments performed in duplicate on cells obtained from three
representative CD41 lymphocyte response of one subject out of six different subjects.
tested. Five subjects had significant lymphocyte response to a-toxin,
and three to Tetanus toxoid. *P , 0.05 over control reaction without
antigen; **P , 0.01.
RT-PCR products in triplicate taken at zero, two, four,
and eight hours following IFN-g stimulation. The figure
shows low basal levels at time 0 and an increase in IL-15was found to be an efficient IL-15 inducer, increasing
IL-15 levels over fivefold from control levels at 24 hours. mRNA levels as early as four hours from IFN-g stimula-
tion, with an additional small increase at eight hours.The dose response of HPMCs to increasing IFN-g
levels showed a very sensitive response starting from a The increase in IL-15 mRNA levels following IFN-g
stimulation at 16 hours was between 1.8- and 3.1-fold,low concentration of 0.5 U/mL, reaching plateau levels
at 5 U/mL (Fig. 6). depending on the assay (data not shown). Accumulation
of IL-15 to supernatant of control and IFN-g stimulatedUp-regulation of IL-15 mRNA in HPMCs was assayed
by RT-PCR. Figure 7 shows a representative gel electro- HPMCs is shown in Figure 8. Significant IL-15 protein
levels were found as early as 12 hours from stimulationphoresis and densitometry of IL-15 and control b-actin
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Fig. 6. IFN-g dose response. HPMCs were stimulated with increasing
IFN-g doses (0.5 to 500 U/mL) for 24 hours, and then total IL-15 levels
were determined. *P , 0.05 over unstimulated control (0 U/mL). The
results are mean 6 se of a representative experiment performed in
triplicate, out of three experiments performed on cells obtained from
different subjects.
Fig. 7. IL-15 mRNA levels following IFN-g stimulation. (A) HPMCs
were stimulated with IFN-g (500 U/mL) for two, four, and eight hours.
Then RNA was extracted, and RT-PCR was performed using specific
with a linear accumulation up to 36 hours. Some basal primers for IL-15 and b-actin. On each lane, the IL-15 product with
the respective b-actin product as the control was run on ethidiumaccumulation of IL-15 could also be found in control
bromide-stained agarose gel. Two additional preparations from differ-HPMCs, reaching statistical significance at 36 hours.
ent donors were studied and yielded similar results. (B) The ethidium
bromide emission intensity of the bands was evaluated using a UVP
Interleukin-15 levels in peritoneal effluents of CAPD- GDS 5000 video system and software (UVP Inc.). The emission ratio
of unstimulated experiments (0 hour) was normalized to 100, and alltreated patients
the other samples were adjusted accordingly. The data are presented
To confirm the in vitro results with the in vivo data, we as mean 6 se of IL-15/b-actin emission ratio of three experiments
performed in triplicate.measured IL-15 levels in peritoneal effluents of patients
undergoing CAPD treatment suffering from peritonitis.
As depicted in Figure 9, significantly elevated IL-15 lev-
els (35.0 6 6.0 pg/mL) were found in dialysis effluents of
patients with peritonitis compared with healthy patients
(16.2 6 4.0 pg/mL).
DISCUSSION
Antigen presentation and T-cell activation are the first
steps in the generation of a specific immune response.
During this process, cytokines are secreted from Th and
APC and activate the cellular and humoral immune re-
sponses. Valle et al have demonstrated that HPMCs
are able to present TT and Candida albicans bodies to
mononuclear cells depleted of adherent cells and to a
T-cell clone [13]. To prevent the presence of professional
APC in our experimental model, we have used magnetic-
affinity methods to obtain highly purified Th cells, de- Fig. 8. IL-15 secretion from HPMCs. Supernatants were collected
pleted of B cells, dendritic cells, and monocytes. We from control (h) or IFN-g (j; 500 U/mL) stimulated HPMC at various
time points (0 to 36 hours). *P , 0.05 over unstimulated control (0found that in the absence of professional APC, HPMCs
hour). The results are mean 6 se of a representative experiment
effectively induced the proliferation of CD41 Th cells performed in triplicate, out of three experiments performed on cells
obtained from different subjects.when the antigen TT or the super antigen S. aureus
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a constitutive expression of HLA-DR molecules on
HPMCs [13]. Expression of class 2 molecules by unstimu-
lated nonprofessional APC is infrequently described [9].
Therefore, the detection of elevated HLA-DR expres-
sion on resting HPMC by Valle et al could be explained
by nonspecific binding of the detection antibody used
for flow cytometry experiments or by nonspecific activa-
tion of the HPMC by one of the medium constituent.
Interferon-g was found in supernatants of T cells dur-
ing response to TT; however, IFN-g addition prior or
during the AP reaction had no significant effect on
T-cell response to antigens, suggesting that the levels
produced by the T cells are sufficient for maximal re-
sponse. Therefore, class 2 molecules are probably in-
duced on HPMCs by low amounts of IFN-g released
Fig. 9. IL-15 levels in peritoneal effluents. The morning dialysis efflu- from T cells during the assay. Even if at the beginning
ents of patients undergoing CAPD treatment were collected, and sam-
of the assay IFN-g is low and only a limited number ofples were analyzed by ELISA for IL-15 levels. (Control) This indicates
peritoneal fluids from patients free of peritonitis for at least three HPMC express class 2 molecules, those cells present
months (N 5 7). (Peritonitis) This indicates peritoneal fluids from the antigen and further activate T cells to release more
patients with acute peritonitis (N 5 10). The horizontal lines indicate
IFN-g, a process that concludes with full HPMC activa-the mean values.
tion.
Interferon-g was also a key factor in activation of
HPMCs to produce IL-15. IL-15 is a pleotropic cytokine
a-toxin are present. In the presence of HPMCs, T cells with many activities related to cell-mediated immunity.
were always responsive to direct CD3 activation by One major activity of IL-15 is its T-cell growth factor
OKT3 antibodies, and only half of the cases (3 out of 6) activity [14]. We tested whether HPMCs respond to the
responded to TT. The TT nonresponsive T cells re- major T-cell cytokines IL-2 and IFN-g. In contrast to
mained unresponsive when HPMCs were replaced with their unresponsiveness to IL-2, HPMCs reacted to IFN-g
professional APC (monocytes), suggesting that this unre- by producing IL-15 in a dose-dependent manner. Sig-
sponsiveness is not HPMC related. Thus, the nonrespon- nificant up-regulation of IL-15 was seen initially at the
sive T-cell preparations had only limited or no TT- mRNA level following 4 hours of stimulation by IFN-g,
responsive T cells. In addition, IL-2 and IFN-g were and at 12 hours from induction, significant amounts of
present in the supernatants of TT-responsive cells and IL-15 protein could be found in HPMC supernatants.
were absent from the nonresponsive lymphocytes, indi- Accumulation at a constant rate was seen up to 36 hours.
cating that the nonresponding lymphocyte were not acti- The response of HPMCs to recombinant IFN-g started
vated. at a dose of 0.5 U/mL. We found that during TT-AP,
We found constitutive high levels of ICAM-1 similar there was an accumulation of IFN-g, IL-2, and IL-15.
to that previously reported [6, 13, 24]. Our data indicate The presence of IFN-g (,1 U/mL) could explain the
that ICAM-1 is the major accessory molecule for AP by increasing IL-15 levels secreted from HPMCs. Both IL-2
HPMCs. This is implied by the constitutive expression secreted from CD41 cells and IL-15 secreted from
of ICAM-1 and by blocking of the OKT3-induced HPMCs apparently cooperate in inducing the prolifera-
T-cell proliferation by anti-CD54 (ICAM-1) antibodies. tion of T cells during AP. Kumaki et al support this
In contrast, we have not detected the B7-1 and B7-2 mole- assumption. They demonstrated that IL-15 up-regulates
cules, which are considered to be the major accessory the a chain of the IL-2 receptor and down-regulates its
molecules on professional APC. Similar to our findings own a chain and suggested that by this mechanism, IL-15
in HPMCs, ICAM-1 was demonstrated to be a major ac- cooperates with IL-2 in the initiation of an immune re-
cessory molecule in various nonprofessional APC [9, 12]. sponse and subsequently enhances IL-2 responsiveness
As expected from nonprofessional APC, we found [25]. Interestingly, we found that low IL-15 levels accu-
HLA-DR molecules on HPMCs only upon stimulation mulated in unstimulated cells, reaching significant levels
by IFN-g. These findings are comparable to those of at 36 hours, and also found low IL-15 levels in the perito-
Goodman et al and Topley et al, who did not find any neal effluents of CAPD-treated patients (Fig. 9). Possi-
expression of HLA-DR on quiescent HPMCs [4, 5], simi- bly, in vivo low IL-15 levels may suffice to prevent apop-
lar to Jonjic et al, who found that most unstimulated tosis of peritoneal leukocyte, an assumption supported
mesothelial cells do not express HLA-DR molecules [6], by Carson et al and Girard et al, who demonstrated that
IL-15 at low levels acts as an anti-apoptotic agent forand different from the data of Valle et al, who described
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MCP-1, monocyte chemoattractant peptide-1; MHC, major histocom-NK cells and neutrophils [26, 27]. IL-15 may also be
patibility complex; MMLV-RT, Molony murine leukemia virus-reverse
involved in determining the cell type and differentiation transcriptase; NK, natural killer; OKT-3, anti-CD3 antibody; PBMC,
peripheral blood mononuclear cells; PBS, phosphate buffered saline;of the local leukocyte population. Edelbaum et al and
RT-PCR, reverse transcription-polymerase chain reaction; TCR, T cellWarren demonstrated that IL-15 is an activator and dif-
receptor; Th, T helper; TT, Tetanus toxoid.
ferentiation factor for NK cells and an effective growth
factor for gamma-delta T cells [28, 29]. Thus, the pres-
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